Skip to Content

  • Search

View Additional Section Content

A Phase 2 multi-center, randomized, double-blind, placebo controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer’s Disease (US202)

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02079909?term=nct02079909&rank=1

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details